List of Figures
Figure 1. Antiviral Drug Resistance Market Segmentation
Figure 2. Antiviral Drug Resistance Segmentation, by Region
Figure 3. Asia Pacific Antiviral Drug Resistance Market, Revenue (US$ Mn), 2018 & 2027
Figure 4. Global Antiviral Drug Resistance Market By Product, Market Share (%), 2018
Figure 5. Global Antiviral Drug Resistance Market By Disease Indication, Market Share (%), 2018
Figure 6. Global Antiviral Drug Resistance Market By Technology, Market Share (%), 2018
Figure 7. Global Antiviral Drug Resistance Market By End User, Market Share (%), 2018
Figure 8. North America : PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia - Pacific: PEST Analysis
Figure 11. Middle East & Africa: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Antiviral Drug Resistance Market Impact Analysis of Driver and Restraints
Figure 14. Global Antiviral Drug Resistance Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 15. Global Antiviral Drug Resistance Market – by Geography Forecasts and Analysis – 2018- 2027
Figure 16. Prominent Players in the Antiviral Drug Resistance Market
Figure 17. Global Antiviral Drug Resistance Market Share by Product 2018 & 2027 (%)
Figure 18. Kits and Reagents Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Instruments Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Global Antiviral Drug Resistance Market Share by Disease Indication 2018 & 2027 (%)
Figure 21. HIV Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 22. Hepatitis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Cytomegalovirus (CMV) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Global Antiviral Drug Resistance Market Share by Technology 2018 & 2027 (%)
Figure 25. Immunodiagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Polymerase Chain Reaction (PCR) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Next Generation Sequencing (NGS) Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 28. Other Technologies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Global Antiviral Drug Resistance Market Share by End User 2018 & 2027 (%)
Figure 30. Hospitals And Clinics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Pathology And Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. RESEARCH INSTITUTES Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. North America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 34. North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. North America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 36. US Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 37. Canada Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Mexico Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Europe Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 40. Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Europe Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 42. UK Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Germany Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. France Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Italy Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Asia Pacific Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 48. Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. Asia Pacific Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 50. Japan Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. China Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. India Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 53. South Korea Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. Australia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 55. Middle East & Africa Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 56. Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. Middle East & Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 58. UAE Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 59. Saudi Arabia Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. South Africa Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 61. South and Central America Antiviral Drug Resistance Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 62. South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. South and Central America Antiviral Drug Resistance Market Revenue and Forecasts to 2027, By Country (%)
Figure 64. Argentina Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 65. Brazil Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)


List of Tables
Table 1. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 2. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 3. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 4. North America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 5. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 6. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 7. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 8. US Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 9. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 10. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 11. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 12. Canada Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 13. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 14. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 15. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 16. Mexico Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 17. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 18. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 19. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 20. Europe Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 21. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 22. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 23. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 24. UK Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 25. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 26. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 27. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 28. Germany Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 29. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 30. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 31. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 32. France Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 33. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 34. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 35. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 36. Italy Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 37. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 38. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 39. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 40. Spain Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 41. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 42. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 43. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 44. Asia Pacific Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 45. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 46. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 47. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 48. Japan Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 49. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 50. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 51. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 52. China Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 53. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 54. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 55. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 56. India Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 57. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 58. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 59. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 60. South Korea Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 61. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 62. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 63. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 64. Australia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 65. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 66. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 67. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 68. Middle East & Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 69. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 70. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 71. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 72. UAE Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 73. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 74. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 75. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 76. Saudi Arabia Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 77. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 78. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 79. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 80. South Africa Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 81. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 82. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 83. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 84. South and Central America Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 85. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 86. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 87. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 88. Argentina Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 89. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 90. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
Table 91. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 92. Brazil Antiviral Drug Resistance Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 93. Glossary of Terms, Antiviral Drug Resistance Market